FC25: Keep the Conversation Going: Optimizing Psoriatic Disease Outcomes With GLP-1 Receptor Agonists
Released on
October 24, 2025
FC25: Keep the Conversation Going: Optimizing Psoriatic Disease Outcomes With GLP-1 Receptor Agonists
This activity is supported by an educational grant from Lilly.